Business Development Analyst - Director - Zurich

Lieu: Switzerland - Glattbrugg/Zurich

Fonction: Strategy

Niveau de Séniorité: Director

Ramiro Villanueva

Senior Talent Acquisition Manager

Conditions pour les agences de placement

Votre profil

An expert in finance and business modelling with emphasis on development stage life sciences companies, products and services


  • University degree in Biology/Chemistry/Medicine/Applied Biosciences with 8 years of work experience in relevant corporate positions within the Life Sciences Industry (Pharma/Biotech/Medtech) and/or Investment Banking. Firm understanding of the general drug discovery, development and commercialization process is a requirement
  • Strong analytical and conceptual skills. Further business and administration education (e.g. MBA) and / or first experience in Financial Analysis (e.g. CFA) would be an important additional asset
  • Interest in working in a dynamic and international work environment. Ability to communicate and work in interdisciplinary teams
  • Open and communicative personality. High client orientation and passion for close collaboration with a wide range of stakeholders. Ability to deliver high quality work under time pressure
  • Self-motivated and results-driven personality
  • Excellent oral and written communication skills in English and German

Job description:

  • The candidate will report to the Head Business Development and Licensing (BD&L)
  • BD&L as a department is embedded in the Strategy Department at the operational Headquarters in Zurich. The Strategy Department Head as a member of the Executive Committee reports directly into the CEO of Vifor Pharma and oversees other commercial and medical functions, such as Research, Pre-Clinical Development, Program Management and Regulatory Affairs. This proximity allows BD&L to cooperate closely with other departments and align with the strategic needs of the overall organization
  • The candidate will seek out and generate data required to build robust BD&L business cases (financial models) that are aligned with insights generated during the due diligence process. If the research includes external consultants or service providers, the candidate will manage such resources by himself (recruitment, briefing, definition of deliverables, etc.)
  • In performing this task, the candidate will collaborate closely with stakeholders and data providers of adjacent departments, namely Market Analytics, Medical Affairs, Regulatory, Market Access and Clinical Development. Important aspects to consider for the business case development are:
    • Epidemiology and patient flow
    • Standard of care
    • Medical need
    • Competitive landscape
    • Target product profile
    • Pricing
    • Uptake and market share
    • Commercialization costs
    • Etc.
  • The candidate will generate content for presentations to the Executive Committee and the Board of Directors of Vifor Pharma
  • The candidate will be considered the “data owner” in regards to BD&L business cases and will assist in the transition of those business cases to Corporate Finance and Project Management once a deal is closed
  • As a secondary objective, the candidate will support efforts to identify new companies, new products and services and ultimately new investment ideas that are in alignment with the strategic needs of the Vifor Pharma Group
  • The candidate will be part of a BD&L department and participate with his other team members in the early evaluation and project triage of newly identified opportunities (deal flow)

A propos de nous

Le groupe Vifor Pharma est une entreprise pharmaceutique internationale spécialisée. Son ambition est de devenir le leader mondial dans les domaines de la carence en fer, de la néphrologie et des traitements cardio-rénaux. L’entreprise est le partenaire de choix pour les médicaments et les solutions innovantes axées sur le patient. Le groupe Vifor Pharma aspire à aider les patients du monde entier atteints de maladies graves et chroniques à mener une vie meilleure et plus saine. La société développe, fabrique et commercialise des produits pharmaceutiques offrant des soins de précision aux patients. Le groupe Vifor Pharma occupe une position de premier plan dans toutes ses activités clés. Il se compose des entreprises suivantes: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (sa société commune avec Fresenius Medical Care); et OM Pharma.

Le groupe Vifor Pharma a son siège en Suisse et est coté à la Bourse suisse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

Pour de plus amples informations, veuillez consulter

Afficher/masquer le contenu

Xing Send to a friend

Conditions pour les agences de placement